Evotec Receives Grants to Advance Tuberculosis Treatment

Go back to Evotec Receives Grants to Advance Tuberculosis Treatment
EATON VANCE OHIO MUNI INCOME T (NASDAQ: EVO) Delayed: 2.64 +0.02 (0.76%)
Previous Close $2.62    52 Week High $16.39 
Open $2.60    52 Week Low $13.22 
Day High $2.68    P/E N/A 
Day Low $2.60    EPS $-1.61 
Volume 16,427